# Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.

> **NCT05835934** · PHASE1 · COMPLETED · sponsor: **Haisco Pharmaceutical Group Co., Ltd.** · enrollment: 6 (actual)

## Conditions studied

- Peripheral Analgesic and Anti-itch

## Interventions

- **DRUG:** [14C]HSK21542

## Key facts

- **NCT ID:** NCT05835934
- **Lead sponsor:** Haisco Pharmaceutical Group Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-15
- **Primary completion:** 2021-09-10
- **Final completion:** 2021-12-20
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05835934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05835934, "Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK21542 in Healthy Adult Male Volunteers.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05835934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*